Name | Price | Price Change | Analyst Price Target | Market Cap | Yearly Gain | Analyst Consensus | Smart Score | Follow |
---|---|---|---|---|---|---|---|---|
Gilead Sciences | $65.34 | $72.00 (10.19% Upside) | $82.75B | -4.85% | 4Buy 9Hold 0Sell Moderate Buy | premium | ||
Amgen | $250.86 | $242.69 (-3.26% Downside) | $134.04B | 14.97% | 4Buy 8Hold 2Sell Hold | premium | ||
Vertex Pharmaceuticals | $299.04 | $294.76 (-1.43% Downside) | $76.74B | 50.89% | 10Buy 7Hold 0Sell Moderate Buy | premium | ||
Biogen | $214.09 | $239.88 (12.05% Upside) | $31.57B | -36.11% | 10Buy 9Hold 0Sell Moderate Buy | premium | ||
Illumina | $202.75 | $255.38 (25.96% Upside) | $33.47B | -55.55% | 4Buy 8Hold 1Sell Hold | premium | ||
Regeneron | $618.36 | $669.69 (8.30% Upside) | $69.37B | -4.70% | 7Buy 8Hold 1Sell Moderate Buy | premium | ||
Moderna | $146.10 | $217.89 (49.14% Upside) | $61.81B | -60.83% | 4Buy 5Hold 1Sell Moderate Buy | premium | ||
IQVIA Holdings | $239.02 | $267.50 (11.92% Upside) | $44.88B | -6.95% | 12Buy 0Hold 0Sell Strong Buy | premium | ||
Mettler-Toledo | $1333.80 | $1,267.75 (-4.95% Downside) | $30.53B | -11.86% | 0Buy 2Hold 2Sell Moderate Sell | premium | ||
BioNTech SE | $147.92 | $211.00 (42.64% Upside) | $36.90B | -55.09% | 4Buy 6Hold 0Sell Moderate Buy | premium |